Brief: Creative Medical Tech Announces Positive Top-Line Results For Type 2 Diabetes Study
12/04/2023 14:03
April 12 (Reuters) - Creative Medical Technology
Holdings Inc CELZ.O :
* CREATIVE MEDICAL TECHNOLOGY ANNOUNCES POSITIVE TOP-LINE
RESULTS
FOR TYPE 2 DIABETES STUDY
* CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC - ONE-YEAR
FOLLOW-UP
RESULTS CONFIRM SIGNIFICANT EFFICACY
* CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC - NO SERIOUS
ADVERSE
EFFECTS IN PATIENTS USING CELZ-001 FOR TREATING TYPE 2 DIABETES
Source text for Eikon: ID:nPn8ZP446a
Further company coverage: CELZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Creative Medical Technology Holdings
See all newsBrief: Creative Medical Technology Buys 4 Million Biodefense Shares For $200,000 Cash And 1 Million Shares On Sept 24
Brief: Creative Medical Technology Holdings Successfully Completes Enrollment And Treatment Across Entire FDA-Cleared Adapt Trial, Including Opioid Cohort, Advancing Celz-201 / Olastrocel Toward Rmat Evaluation And Phase 3 Planning
Creative Medical Technology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
NASDAQ RESUMED AT 11:07 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:02 AM